Patents by Inventor Kenneth J. Pienta

Kenneth J. Pienta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210395666
    Abstract: An embodiment in accordance with the present invention provides two devices for the isolation of rare cell populations such as circulating tumor cells (CTCs). Both devices use magnetic fields to manipulate cells that are bounded to paramagnetic particles (PMP). One device uses surface tension and a sieve for cell filtration, whereas the other allows for the direct transfer of cells onto a standard microscope slide. Subsequent processing steps may be directly performed on the devices thereby minimizing cell losses. The first device is referred to as the ST (surface tension) device and the second device is referred to as the DT (direct transfer) device. The ST device can also be considered as a chip for the isolation of the rare cell populations.
    Type: Application
    Filed: September 3, 2021
    Publication date: December 23, 2021
    Inventors: Dan Stoianovici, Kenneth J. Pienta, Michael A. Gorin
  • Publication number: 20210116447
    Abstract: An embodiment in accordance with the present invention provides a method and device that leverages a controlled scanning process for CTC-antibody binding, rather than classic random mixing. Magnetophoretic direct extraction is used to extract the CTCs onto a standard microscope slide. A device according to the present invention includes a vial into which a CTC bearing solution is combined with antibody-bound-PMP beads. An electromagnet is used to apply a magnetic field to engage the beads along the magnetic lines across the vial. The magnetic field and in turn the beads are moved on a fine pitch helical trajectory. The entire volume of the vial is scanned in this manner, allowing beads to come into close proximity to any CTCs present, and to collect all of the CTCs in the vial.
    Type: Application
    Filed: November 29, 2018
    Publication date: April 22, 2021
    Inventors: Dan Stoianovici, Doru Petrisor, Changhan Jun, Kenneth J. Pienta
  • Publication number: 20190127680
    Abstract: An embodiment in accordance with the present invention provides two devices for the isolation of rare cell populations such as circulating tumor cells (CTCs). Both devices use magnetic fields to manipulate cells that are bounded to paramagnetic particles (PMP). One device uses surface tension and a sieve for cell filtration, whereas the other allows for the direct transfer of cells onto a standard microscope slide. Subsequent processing steps may be directly performed on the devices thereby minimizing cell losses. The first device is referred to as the ST (surface tension) device and the second device is referred to as the DT (direct transfer) device. The ST device can also be considered as a chip for the isolation of the rare cell populations.
    Type: Application
    Filed: April 21, 2017
    Publication date: May 2, 2019
    Inventors: Dan Stoianovici, Kenneth J. Pienta, Michael A. Gorin
  • Patent number: 5925531
    Abstract: The present invention provides immortalized human bone marrow endothelial cells which are useful for the study of tumor metastasis. In particular, the human bone marrow endothelial cell lines provided by the invention provide an in vitro model system for screening compounds for the ability to reduce, prevent, or inhibit the metastasis of cancer cells to bone tissue.
    Type: Grant
    Filed: October 23, 1997
    Date of Patent: July 20, 1999
    Assignee: The Regents of the University of Michigan
    Inventor: Kenneth J. Pienta
  • Patent number: 5895784
    Abstract: A method for the treatment of cancer in mammals. A subject afflicted with cancer receives by oral administration a pH modified citrus pectin which inhibits metastasis of primary tumors.
    Type: Grant
    Filed: January 2, 1997
    Date of Patent: April 20, 1999
    Assignees: Michigan Cancer Foundation, Wayne State University
    Inventors: Avraham Raz, Kenneth J. Pienta
  • Patent number: 5834442
    Abstract: A method for the treatment of cancer in mammals. A subject afflicted with cancer receives by oral administration a pH modified citrus pectin which inhibits metastasis of primary tumors.
    Type: Grant
    Filed: July 7, 1994
    Date of Patent: November 10, 1998
    Assignees: Barbara Ann Karmanos Cancer Institute, Wayne State University
    Inventors: Avraham Raz, Kenneth J. Pienta